InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,075.86
(
-3.47%
)

Replies to post #883 on Aurinia Pharmaceuticals Inc (AUPH)

Replies to #883 on Aurinia Pharmaceuticals Inc (AUPH)

tjguy

03/03/17 8:09 AM

#884 RE: Lunacy_John Galt #883

Oh, I got it. Thanks.

nferna

03/03/17 9:03 AM

#887 RE: Lunacy_John Galt #883

Negative. It is a 52 week trial. Primary outcome measure at 24 weeks, Secondary outcome measures at 12, 24 and 52 weeks.

https://clinicaltrials.gov/ct2/show/NCT03021499?term=voclosporin&rank=4